Clinical Trials Logo

Parkinson Disease clinical trials

View clinical trials related to Parkinson Disease.

Filter by:

NCT ID: NCT04228887 Completed - Parkinson Disease Clinical Trials

Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease

Start date: May 4, 2018
Phase: N/A
Study type: Interventional

In this study investigators will examine the effects of inspiratory muscle training and balance training in patients with Parkinson's Disease

NCT ID: NCT04228523 Completed - Parkinson Disease Clinical Trials

Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)

ETPARK-REMED
Start date: February 24, 2020
Phase: N/A
Study type: Interventional

Dopaminergic drug can have adverse effects leading to potential serious consequences. Therapeutic patient education must promote the understanding of drugs to improve its management. This study tries to evaluate the effect of therapeutic education workshop on Parkinson disease's drug (drug workshop) on the evolution of drug's representations in patients with Parkinson's disease compared to a control group.

NCT ID: NCT04223245 Completed - Parkinson Disease Clinical Trials

A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease

Start date: June 29, 2017
Phase: N/A
Study type: Interventional

People with Parkinson Disease (PWPD) have significant problems with velocity, safety and dual tasking during walking that may be secondary to poor automaticity. Sensory functions, especially visual dependence and proprioceptive integration are critical for efficient walking and are often impaired. This home program compares the use of multimodal sensory feedback during stepping and balance exercises in PWPD to a group without the sensory feedback performing the same basic exercises.

NCT ID: NCT04215900 Completed - Parkinson Disease Clinical Trials

High-Speed Yoga and Executive Function

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

The purpose of this research study is to establish if a novel high-speed yoga program which incorporates visual cues can make a positive change in the participant's ability to make decisions and move as measured by several cognitive, balance and functional tests. It has been shown that yoga can improve balance and movement in those diagnosed with Parkinson's disease.

NCT ID: NCT04203615 Completed - Parkinson Disease Clinical Trials

Effect of Noninvasive Brain Stimulation on Hypokinetic Dysarthria in Parkinson's Disease

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Hypokinetic dysarthria (HD) is common in Parkinson's disease (PD) patients and responds only partially to pharmacotherapy and surgery. The investigators will explore long-term effects of repetitive transcranial magnetic stimulation (rTMS) applied over right superior temporal gyrus, brain area known to be engaged in the feedback control of voiced speech. The project results will allow for the identification of potential therapeutic effects of rTMS as a tool that could contribute to the speech therapy of HD in PD patients. The results will also enhance our understanding of brain mechanisms underlying specific long-term effects of rTMS.

NCT ID: NCT04202757 Completed - Clinical trials for Idiopathic Parkinson Disease

Intravenous Plasma Treatment for Parkinson's Disease

yFFP
Start date: September 24, 2018
Phase: Early Phase 1
Study type: Interventional

This study will do a preliminary evaluation of a possible treatment for mild-to-moderate Parkinson's disease. Patients will be treated with either transfusions of plasma from young donors. or with placebo transfusions. In the following several months, Parkinson's symptoms will be monitored and compared for the two groups.

NCT ID: NCT04196647 Completed - Parkinson Disease Clinical Trials

Guideline for Hometitration With Duodopa for Parkinson Patients

Start date: March 1, 2017
Phase:
Study type: Observational

The purpose of this study is to 1. Create a guide for hometitration of Duodopa for patients with Parkinson's disease 2. Outline which patients could be considered for "hometitration"

NCT ID: NCT04193527 Completed - Essential Tremor Clinical Trials

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Start date: June 28, 2020
Phase: Phase 3
Study type: Interventional

This is a multicenter, open-label, non-controlled, non-randomized, phase 3 clinical study to compare the SPECT findings after a single IV administration of DaTSCAN™ ioflupane (123I) injection for patients with a clinical diagnosis of Parkinsonian syndrome (PS) involving striatal dopaminergic deficit (SDD; specifically, Parkinson's disease [PD] [SDD], multiple system atrophy [MSA] [SDD] or or progressive supranuclear palsy [PSP] [SDD]) as compared with patients with a clinical diagnosis of essential tremor (ET) (no SDD) and age-matched healthy controls.

NCT ID: NCT04191577 Completed - Parkinson Disease Clinical Trials

Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

Start date: December 2, 2019
Phase: Phase 2
Study type: Interventional

This is a phase 2 study, randomized, double-blind, placebo-controlled, multicenter study of oral CVN424 at two dose levels (low-dose and high-dose) in Parkinson's disease (PD) patients with motor fluctuations.

NCT ID: NCT04189887 Completed - Parkinson Disease Clinical Trials

Single Bout Exercise on Learning in PD

Start date: November 27, 2019
Phase:
Study type: Observational [Patient Registry]

Parkinson's disease (PD) is a neurodegenerative disorder associated with a loss of dopamine in the basal ganglia and is characterized by several cardinal motor signs. In addition to the commonly recognized motor symptoms, cognitive impairments are also often observed in people with PD. Unlike motor deficits, cognitive impairments are not always responsive to dopaminergic treatment. While medication may ameliorate some cognitive dysfunctions (e.g., executive function), it may exacerbate others (e.g., motor learning). Therefore, it is crucial for clinicians to look for treatment approaches, other than medication, to enhance cognitive function. In this proposed study, the investigators are especially interested in determining a method to enhance motor learning ability in people with PD. Motor learning deficits in people with PD have been well established through different tasks including motor adaptation task such as maintain balance on a stabilometer or motor sequence task such as performing a serial reaction time task (SRTT). Motor sequence learning is important in acquiring real-life motor skill such as tying shoes laces. Based on the past evidences, people with PD have impairments in motor sequence learning, particularly in implicit sequence learning. Since implicit motor sequence learning constitutes a critical part of everyday activities such as typing and changing clothes, establishing an approach to enhance implicit sequence learning is important. In the literature conducted with non-disable adults, one of the most effective method to enhance motor learning is aerobic exercise. Only one study, to the best of knowledge, has investigated the effect of aerobic exercise on learning to maintain balance on a stabilometer in people with PD. To date, no study has investigated whether a single bout of aerobic exercise could improve implicit sequence learning in PD. Therefore, the goal of this proposed study is to investigate the effect of a single bout of aerobic exercise on implicit sequence learning and the associated neurophysiological changes in people with PD.